Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Minnesota › Minneapolis
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Minneapolis, MN keessatti
Qorannoo 8 Luukemiya Limfoositiikii Keessummaa f Minneapolis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Namoota walitti qabaa jiraSadarkaa 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · Miili 5 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · Miili 5 fagaatti
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Namoota walitti qabaa jiraSadarkaa 3
- Minneapolis VA Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · Miili 5 fagaatti
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
- University of Minnesota, Minneapolis
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Namoota walitti qabaa jiraSadarkaa 3
- Regions Hospital ( Site 0042), Saint Louis Park · Miili 5 fagaatti
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 1
- University of Minnesota, Minneapolis
Allo HSCT Using RIC and PTCy for Hematological Diseases
Namoota walitti qabaa jiraSadarkaa 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Namoota walitti qabaa jiraSadarkaa 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Washington, DCQorannoo 22
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 19
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Cincinnati, OHQorannoo 14
- Chicago, ILQorannoo 14
Qorannoo biroo Minneapolis keessatti
- Saree OljooQorannoo 27
- Kansara Qara'a Non-Small CellQorannoo 26
- Kansarii OvariiQorannoo 24
- Kansarii ProstateQorannoo 23
- Saree (Gosoota Hunda)Qorannoo 22
- Cufama OnneeQorannoo 21
- Dhibee QaraQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 20
- Kansarii ColorectalQorannoo 19
- Kansa EndometiriyaaliiQorannoo 18
- Dhibee ParkinsonQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 15
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.